Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Weeks & Leo Co Inc
EIR
•Weeks & Leo Co Inc•April 7, 2022

Weeks & Leo Co Inc – FDA EIR, Apr 7, 2022

Record Details

A comprehensive surveillance inspection of Weeks and Leo Co., Inc., a human drug manufacturer and contract re-packer located in Clive, IA, was conducted by the FDA from April 4 to April 7, 2022. The inspection, performed under regulatory guidelines for drug manufacturing and repackaging (CP 7356.002 and CP 7356.002B), revealed significant deficiencies, resulting in a six-item FDA Form 483. Key violations included a repeated failure to thoroughly investigate unexplained discrepancies and batch failures. Specific issues highlighted inadequate investigations into leaking product containers and multiple consumer complaints reporting severe burning sensations from a Capsaicin product, with several adverse events not properly investigated. The company also failed to establish appropriate controls over computer systems to ensure authorized changes, and its laboratory controls lacked scientifically sound specifications and testing procedures for raw materials like glycerin (for diethylene glycol) and alcohol (for methanol), as well as for water systems. Deficient complaint records, often missing adverse event determinations and investigation findings, were noted. Additionally, time limits for production phases were not established, leading to product and materials being held for extended periods. Discussions with management also addressed issues with inadequate storage and retention of reserve samples and the co-mingling of quarantined and released products. These observations indicate a need for the company to implement comprehensive corrective and preventative actions to achieve compliance with manufacturing quality standards.

Company
Weeks & Leo Co Inc
Inspection date
April 7, 2022
Product type
drugs
Office
Chicago District Office
People
  • Darrin Waite (company_representative)
  • Achyut Sahasra (company_representative)
  • Lisa L. Flores (Consumer Safety Officer/ Federal Investigator)
  • Gretchen L. Trendel
  • Patrick A. Neibergall (company_representative)
View Company Profile

ID · cbdb2944-7d4e-4d26-8707-b98719e90f07

Violation Codes7
21 CFR 211.160(b)21 CFR 820.19821 CFR 211.11121 CFR 211.68(b)21 CFR 211.198(b)(2)21 CFR 211.19221 CFR 211.110(b)

Full citation text and observation details available on the Dashboard.

Other documents for Weeks & Leo Co Inc
  • 483 - 2022-04-07April 7, 2022
  • EIR - 2018-03-29March 29, 2018
  • 483 - 2018-03-29March 29, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Weeks & Leo Co Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.